Sandbox Reserved 1499
From Proteopedia
m |
m |
||
Line 1: | Line 1: | ||
{{Sandbox_Reserved_ESBS}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | {{Sandbox_Reserved_ESBS}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
==Penicillin-binding protein 6 from ''Escherichia coli''== | ==Penicillin-binding protein 6 from ''Escherichia coli''== | ||
- | The Penicillin-binding protein 6 (PBP6) from ''Escherichia coli'' is a DD-carboxypeptidase which plays an important role in the creation of the bacterial cell wall. It belongs to the group of PBP of low molecular mass. Its structure was determined by Chen et al.<ref>PMID:19807181</ref>. These results allow for the study of the | + | The Penicillin-binding protein 6 (PBP6) from ''Escherichia coli'' is a DD-carboxypeptidase which plays an important role in the creation of the bacterial cell wall. It belongs to the group of PBP of low molecular mass. Its structure was determined by Chen et al.<ref>PMID:19807181</ref>. These results allow for the study of the functioning of the active site of PBP6 and of the role of pentapeptidic imitation by ampicillin. |
__TOC__ | __TOC__ | ||
Line 35: | Line 35: | ||
Ampicillin stops the synthesis of peptidoglycan by competitive inhibition of PBP6. [[3ita]] shows the acylenzyme complex of PBP6 with ampicillin. | Ampicillin stops the synthesis of peptidoglycan by competitive inhibition of PBP6. [[3ita]] shows the acylenzyme complex of PBP6 with ampicillin. | ||
- | Ampicillin presents structural characteristics which are similar to the PBP6's substrate. These characteristics allow it to bind to the enzyme and access its active site. It however also possesses characteristics which allow it to stop the enzyme from | + | Ampicillin presents structural characteristics which are similar to the PBP6's substrate. These characteristics allow it to bind to the enzyme and access its active site. It however also possesses characteristics which allow it to stop the enzyme from functioning. |
It uses the same mechanisms as the enzyme substrate <scene name='80/802673/Active_site_amp/2'>to insert itself into the active site</scene>. Thanks to its O3 carboxylate group for example, it can mimic the carbonyl oxygen from the peptide bond and make use of the oxyanion hole described previously. The oxygen atom in question additionally forms a hydrogen bond with the Thr212 side chain. | It uses the same mechanisms as the enzyme substrate <scene name='80/802673/Active_site_amp/2'>to insert itself into the active site</scene>. Thanks to its O3 carboxylate group for example, it can mimic the carbonyl oxygen from the peptide bond and make use of the oxyanion hole described previously. The oxygen atom in question additionally forms a hydrogen bond with the Thr212 side chain. | ||
Line 47: | Line 47: | ||
== Relevance== | == Relevance== | ||
- | The resolution of this structure plays an important role in understanding the exact method of action of beta-lactam antibiotics<ref>DOI 10.1016/j.mib.2010.09.008</ref>. Since antibiotic resistance is often based on small changes in protein conformation at the molecular level, it is important to understand the method of action of antibiotics in their every detail, so that treatments for | + | The resolution of this structure plays an important role in understanding the exact method of action of beta-lactam antibiotics<ref>DOI 10.1016/j.mib.2010.09.008</ref>. Since antibiotic resistance is often based on small changes in protein conformation at the molecular level, it is important to understand the method of action of antibiotics in their every detail, so that treatments for resistant bacteria can be devised. |
== References == | == References == | ||
<references/> | <references/> |
Revision as of 22:22, 11 January 2019
This Sandbox is Reserved from 06/12/2018, through 30/06/2019 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1480 through Sandbox Reserved 1543. |
To get started:
More help: Help:Editing |
Penicillin-binding protein 6 from Escherichia coli
The Penicillin-binding protein 6 (PBP6) from Escherichia coli is a DD-carboxypeptidase which plays an important role in the creation of the bacterial cell wall. It belongs to the group of PBP of low molecular mass. Its structure was determined by Chen et al.[1]. These results allow for the study of the functioning of the active site of PBP6 and of the role of pentapeptidic imitation by ampicillin.
Contents |
Function
As a DD-carboxypeptidase, the function of PBP6 is to participate in the transpeptidation which occurs during the biosynthesis of peptidoglycan[2]. More specifically, it cleaves the peptide bond between the two terminal D-alanines of the pentapeptidic muramyl peptides of sequence L-Ala-D-Glu-m-A2pm-D-Ala-D-Ala. This then allows transpeptidases to create peptidoglycan cross-links which stabilise the cell wall.
The cleavage reaction takes place in two steps.
- Firstly, the PBP6 binds to carbonyl group in the peptide bond between the two terminal D-alanines of the N-acetylmuramic acid. This forms a high-energy tetrahedric intermediate called the acylenzyme.
- The acylenzyme allows the medium to reach the carbonyle group. As a result, a water molecule can attack the group, causing the cleavage of the tetrahedral structure.
Structure
|
Relevance
The resolution of this structure plays an important role in understanding the exact method of action of beta-lactam antibiotics[3]. Since antibiotic resistance is often based on small changes in protein conformation at the molecular level, it is important to understand the method of action of antibiotics in their every detail, so that treatments for resistant bacteria can be devised.
References
- ↑ Chen Y, Zhang W, Shi Q, Hesek D, Lee M, Mobashery S, Shoichet BK. Crystal structures of penicillin-binding protein 6 from Escherichia coli. J Am Chem Soc. 2009 Oct 14;131(40):14345-54. PMID:19807181 doi:10.1021/ja903773f
- ↑ Mattei PJ, Neves D, Dessen A. Bridging cell wall biosynthesis and bacterial morphogenesis. Curr Opin Struct Biol. 2010 Dec;20(6):749-55. doi: 10.1016/j.sbi.2010.09.014., Epub 2010 Oct 26. PMID:21030247 doi:http://dx.doi.org/10.1016/j.sbi.2010.09.014
- ↑ Llarrull LI, Testero SA, Fisher JF, Mobashery S. The future of the beta-lactams. Curr Opin Microbiol. 2010 Oct;13(5):551-7. doi: 10.1016/j.mib.2010.09.008. Epub, 2010 Sep 29. PMID:20888287 doi:http://dx.doi.org/10.1016/j.mib.2010.09.008